932-86 Importance of Collagen in Myocardial Ischemia and Remodeling of Abnormal Intramural Coronary Arteries (“Small Vessel Disease”) in Young Patients with Hypertrophic Cardiomyopathy and Sudden Cardiac Death  by Shirani, Jamshid et al.
118A ABSTRACTS JACC February 1995
H.J.F. Why, \l.B. Patel 1, PJ. Richardson, \l.R. Preedy 1. Department of Cardiology,
King's College Hospital, London, U.K; 1 Department ofBiochemistry, King's College
Hospital, London, U. K
Hypertensive left ventricular hypertrophy(LVH) is associated with altered left
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Altered Muscle Fiber Sarcomeres in Hypertrophic
Cardiomyopathy Associated with the 403Arg-+Gln
P-Myosln Heavy Chain Gene Mutation
Edward B. Lankford, Rhea Levine, Neal D. Epstein 1, Lameh Fananapazir 1. H.
Lee Sweeney. University of Pennsylvania, Phi/adelphia, PA; 1NIH, Bethesda, MD
We have shown that mutant cardiac j3-myosin is present in slow skeletal mus-
cle from patients with hypertrophic cardiomyopathy (HeM) caused by the
403Arg_Gln j3-myosin heavy chain (j3-MHC) gene mutation. Slow myofibers
with this mutation have impaired maximal isometric tension and shortening
velocity. This study examines whether ultrastructural changes account for the
altered contractile properties. Single soleus muscle fibers from 4 patients
(two unrelated kind reds) with the 403Arg_Gln mutation and 3 normal con-
trols, were chemically permeabilized, and mounted under a light microscope
at a length 10% longer than the slack length to measure sarcomeric spac-
ing. Electronmicroscopy was used to evaluate sarcomeric structure of fixed
fibers, as well as to measure the length of thick filaments obtained from elas-
tase digestion of other fibers. Although sarcomeric structure was normal, the
sarcomeric spacing was "'20% shorter compared with normal controls (1.70
versus 2.10 JLm). The isolated thick filaments were also "'20% shorter com-
pared to the normal controls: 1.25 ± 0.14 JLm (n = 248) versus 1.55 ± 0.07
JLm (n ~ 1891, P < 0.001. This reduction of thick filament length and con-
comitant decrease in myosin heads, will (1) reduce the isometric force per
cross-sectional area compared to fibers with normal length, and (2) increase
the maximal shortening velocity as there will be more sarcomeres per unit
length of muscle fiber. This observation suggests that in HCM caused by this
j3-MHC mutation, there is a pathway linking changes in the molecular motor
to alterations in sarcomeric ultrastructure.
Regression of LVH in SHR with Iisinopril treatment was associated with
significantly increased hydroxyproline per unit weight of tissue, protein and
DNA. Selective regression of cardiac proteins with lisinopril may have impor-
tant function implications.
ventricular (LV) filling; this may persist despite regression of LVH with treat-
ment. Collagen occupies about 3% of the LV mass and contributes to my-
ocardial stiffness. Collagen content may be assessed experimentally by as-
say of hydroxyproline, an amino acid virtually unique to collagen. The effects
of lisinopril treatment on LV hydroxyproline content were studied in 15 week
old spontaneously hypertensive rats (SHR) and 15 week old normotensive
Wistar Kyoto rats (WKY). Rats were treated with lisinopril (LIS) in water (5
mglkg/day) for 8 weeks. Control rats were given plain tap water. LV hydrox-
yproline content was assayed by a spectrophotometric method after sacri-
fice. LIS lowered blood pressure (BP) in SHR significantly; BP in WKY was
unaltered. LV mass was significantly greater in SHR controls than WKY con-
trols (1062 ± 40 mg vs 896 ± 9.4 mg, p < 0.01). LV mass regressed with LIS
in both SHR (1062 ± 40 vs 786 ± 18.3 mg, p < 0.001) and WKY (896 ± 9.4
vs 760 ± 33.1 mg, p < 0.01). Hydroxyproline levels were significantly higher
in treated SHR than controls: no difference was seen between treated and
control WKY.
Impaired coronary blood flow reserve and myocardial ischemia in the ab-
sence of epicardial coronary artery disease is a frequent and important patho-
physiologic feature of hypertrophic cardiomyopathy (HCM). To provide the
morphologic basis for such findings, we studied the hearts of 16 pts with
HCM (ages 11-31 yrs; mean 20) who had died suddenly. Transmural sec-
tions of ventricular septum were studied (area 5.2 ± 2 cm2) after staining with
picrosirius-red; 9 ± 2 abnormal intramural coronary arteries (IMCAs)were an-
alyzed per section. Compared to 16 structurally normal control hearts, IMCAs
in HCM had substantially greater (12-fold) collagen volume fraction in media
(2.5 ± 2-vs-0.2 ± 0.3%, p < 0.01). as well as larger outer diameter (120 ±
46-vs-82 ± 22 JLm, p < 0.01). luminal diameter (88 ± 33-vs-62 ± 19 JLm, p <
0.05), medial thickness (32 ± 20-vs-20 ± 6 JLm, p < 0.05) and also perivascular
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thrombin time at a concentration of 23 nmol~ and the activated partial throm-
boplastin time (APTT) at 1.1 JLmol~. Thrombin induced platelet aggregation is
inhibited at an IC50 of 17 nmol~. Inogatran was studied in healthy male hu-
man volunteers with regard to tolerability. pharmacokinetics and effects on
haemostasis. It was given intravenously as a bolus in doses from 0.002 to
1.1 JLmollkg (n = 2-4 at each dose). The highest peak plasma concentration
observed was 7 JLmol~, corresponding to an APTT prolongation of 3 times.
The drug was also given as a constant infusion over 4 h at a dose of 0.73
JLmollkg per h (n = 16) which resulted in a mean plasma concentration at
steady state of 1.9 JLmolll and an APTT prolongation of 2.3 times. Finally, it
was given as a bolus with radiolabeled compound in a total dose of 25 JLmol
(n = 16). The drug was well tolerated and without side effects with the excep-
tion of slightly increased bleeding tendency at the blood sampling site. Ino-
gatran had avolume of distribution of 0.26 mllkg and a total plasma clearance
of 6.1 mllmin per kg, resulting in a half life of about one hour. The drug was
not metabolised and it was excreted unchanged with the elimination evenly
distributed between urine and faeces. Ex vivo the thrombin time was linearly
correlated to the plasma concentration while the APTT-concentration curve
was non-linear. At the highest plasma concentrations a slight prolongation
of the capillary bleeding time was seen in some subjects. Markers of throm-
bin activity (thrombin-antithrombin complex and prothrombin fragments 1-2)
decreased during the constant infusion of the drug. There was no effect on
fibrinolysis (PAI-l and t-PA activities) or protein C. It is concluded that inoga-
tran is a safe and effective anticoagulant with favourable pharmacokinetics
for Lv. use.
We have characterised the age-related changes of contractility and j3-
adrenoceptorfunction in isolated cardiac myocytes from guinea-pigs. Pertus-
sis toxin treatment was used to determine the contribution of Gi effects to the
change in sensitivity to j3-adrenoceptor stimulation. Myocytes were isolated
from either adult animals from 2 weeks to 14 week of age, where bodyweight
increases linearly with age, or senescent ones aged between 53-65 weeks.
There was some indication of a decrease in contractility in maximum Ca2+
with age, with significant differences between a young (::04 weeks, weight
< 400 g) and aged (::.:8 weeks, weight> 600 g) group in contraction ampli-
tude (% shortening) or contraction and relaxation velocities. This decline was
continued into senescence, and ANOVA showed a significant difference be-
tween the three groups for percentage shortening (12.2 ± 0.9%, young, n =
31; 9.5 ± 0.6%, n = 28 aged; 6.7 ± 0.8%, n = 6, senescent; P = 0.005). and
contraction or relaxation velocities (P < 0.001). There was a more pronounced
decline with age for maximum contraction amplitude in isoproterenol (11.8 ±
0.7%. n = 30, young; 7.9 ± 0.5%, n = 28, aged and 5.5 ± 1.1 %, n = 6, senes-
cent; P < 0.001) and the isoproterenollCa2+ ratio was reduced (P < 002). The
EC50 value for isoproterenol was similar in young (1.7 ± 0.4 nM) and aged
(1.6 ± 0.8 nM) animals, but significantly higher in senescent (16.8 ± 6 nM) (P
< 0.05. ANOVA). Pertussis toxin treatment decreased the EC50 in all groups,
but the effect was most pronounced for senescent animals. The final EC50
values in toxin-treated cells were 0.22 ± 0.11 nM (young), 0.19 ± 0.08 nM
(aged) and 0.12 ± 0.01 nM (senescent): these were not significantly differ-
ent. A general decrease in contractility of the myocyte occurs as the animal
ages, but the effect is more pronounced for j3-adrenoceptor stimulation than
for high Ca2+, consistent with a specific lesion in the adenylate cyclase re-
lated pathway. The ability of pertussis treatment to equalise EC50 values for
isoproterenol between the groups suggests that an increase in activity of Gi
contributes to the reduced j3-adrenoceptor sensitivity in senescent animals.
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Transient Adenosine Infusion and Washout
Before Ischemia Protects the Heart Against
Metabolic Damage During Ischemia and
Reperfusion, but Does not Attenuate Stunning in
Pigs - Comparison with Ischemic
Preconditioning
o
*p<.05
o
Prevention of Reoxygenation Injury in Hypoxemic
Immature Hearts by Treatment with Antioxidants
Kai Ihnken, Kiyozo Morita, Gerald D. Buckberg, Georg Matheis, F. Beyersdorf,
M.P Sherman. UCLA Medical School, Los Angeles, CA; J. W Goethe-University,
FrankfurtlMain, Germany
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Introduction; Abrupt reoxygenation of cyanotic immature hearts when start-
ing cardiopulmonary bypass (CPB) produces an "unintended reoxygenation
injury" that is avoidable by treatment with antioxidants. Methods; Nineteen
immature piglets (2-3 weeks) underwent 30 minutes of blood cardioplegic
arrest. Five piglets remained normoxemic (Control). Fourteen piglets were
made hypoxic (paz 20--30 mmHg) for to 2 hours before undergoing reoxy-
genation on CPB. In 8, the pump prime was not supplemented with antioxi-
dants (noRx), whereas MPG (80 mg/kg) and catalase (150 Ulkg) were added
to the pump prime in the 6 others IRx). Myocardial function (Ees, conduc-
tance catheter). oxidant damage (myocardial conjugated dienes (CD) produc-
tion) and antioxidant reserve capacity (AORC, determined by incubating my-
ocardium in the oxidant. t-butyl hydroperoxide, with subsequent measure-
ment of MDA production) were evaluated. Results; Blood cardioplegic arrest
caused no functional and biochemical change in normoxic control immature
piglets. In contrast, hypoxia with subsequent reoxygenation on CPB resulted
in marked conjugated diene production (42 ± 4' vs. 3 ± 1 AZ33 nm/min/100
g), reduced antioxidant reserve capacity (MDA at 4.0 mM of t-BHP: 1342 ±
59' vs. 958 ± 50 nM/g protein), and caused profound myocardial dysfunc-
tion; Ees recovered only 21 ± 2%'. Conversely, adding MPG and catalase to
the pump prime reduced lipid peroxidation (CD production was only 22 ± 7
Az33 nm/min/1 00 g"). restored antioxidant reserve capacity (MDA at 4.0 mM
of t-BHP: 975 ± 139 nM/g protein") and allowed functional recovery (80 ±
8%"1. Conclusion; Reoxygenation of the hypoxemic immature heart by initi-
ating CPB causes oxidant damage and functional depression that nullifies the
cardioprotective effects of blood cardioplegia. Antioxidant supplementation
of the CPB prime limits these detrimental effects, and may be useful in surgi-
cal treatment of cyanotic heart disease. *: p < 0.05 vs. Control, **: p < 0.05
vs. no Rx (ANOVA)
Ryojl Yokota, Hisayoshi FUJiwara, Masami Miyamae, Masaru Tanaka,
Kenzo Yamasaki, Shuji Itoh 1, Keiko Koga 1, Yoichi Yabuuchi 1,
Shigetake Sasayama. Kyoto University, Kyoto, Japan; 1Otsuka Pharmaceutical Co..
lid.. Tokushima, Japan
Recent studies indicate that ischemic preconditioning (IP) may be mediated
by adenosine (ADO) receptor stimulation. This study compared the effects of
adenosine pretreatment on myocardial metabolism and function with those
of 1P. Control hearts (C) underwent 15 min LAD occlusion (occl) followed by
120 min reperfusion (R). ADO (200 /!g/kg/min) was infused into left atrium for
15 min starting at 20 min before LAD occl. IP was elicited by two cycles of
5 min occl & 5 min R. Tissue levels of ATP. creatine phosphate (CP) and pH
in the area at risk were measured by 31 P-MRS, and %segment shortening
(%SS) by sonomicrometry. [Results] ADO infusion decreased blood pressure
(-26%) and heart rate (-13%). and increased three times regional myocar-
dial blood flow (RMBF). However, within 5 min after stopping ADO infusion,
hemodynamic parameters returned to baseline. During sustained ischemia
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Non-Mechanical Energy Expenditure is Preserved
During the Transition from Compensatory
Hypertrophy to Failure of the Left Ventricle in
Dahl Salt-Sensitive Rats
lsao Morii, Yasuki Kihara, Moriaki Inoko, Masashi Kambayashi,
Shigetake Sasayama. Third Division, Department of Internal Medicine, Kyoto University
Faculty of Medicine, Kyoto, Japan
CaZ+ Ees Vo A B
mM mmHg.g.ml-1 mlxl0-Z mlOi .mmHg-l mlOz .beat-1.g-l
·ml- x lO-Z
LVH 1 135Z ± lZ5 1.97 ± 1.Z3 3.Z7 ± 1.45 1.80±0.14
In ~ 5) Z 1853 ± 110' 1.59 ± 0.98 Z.10 ± 0.87 Z.Z7 ± O.ZO'
CHF 1 458 ± 98t 7.33 ± Z.oot 4.05 ± 115 1.18 ± 0.06t
(n ~ 4) Z 649 ± 148,t 5.60 ± 1.56t 3.47 ± 0.86 1.SZ ± O.lS,t
Tumor Necrosis Faetor-a Impairs p-Adrenergic
Responsiveness in Conscious Dogs
David R. Murray, Gregory L. Freeman. UTHSC and AIMVAH, San Antonio, Texas
Dahl salt-sensitive rats fed with a high-salt diet (8% NaCI) progressively de-
velop concentric LV hypertrophy (LVH, 11 weeks), which is followed by LV
dilatation with pulmonary congestion (CHF, 18 weeks). To clarify modulation
in cardiac energetics during the transition from LVH to CHF, we measured
LV pressure-volume area (PVA) and myocardial oxygen consumption (MVOz)
in isolated, isovolumically contracting hearts from this animal model. Hearts
were coronary-perfused with Tyrode's solution at 37°C and were paced at
3.33 Hz (perfusate CaZ+: 1 mM or 2 mM). The perfusion pressure was kept
constant at 140 rnmHg throughout the experiment. paz in the perfusate
and in the coronary effluent were continuously monitored with oxygen elec-
trodes. The end-systolic pressure-volume relation (ESPVR) determined dur-
ing the stepwise changes of the LV volume were fit by a binomial regression
analysis, which provided a slope (Ees) and a volume intercept (Vo). Linear
regression analysis of the MVOz-PVA relation determined a slope (A) and a
MVOz intercept IB).
mean ± SEM. 'p < O.OS vs. CaZ+ 1 mM, paired t-test, and tp < 0.05 vs. LVH. unpaired
t-test
collagen area (41 ± 37-vs-18 ± 10 /!mZ, p < 0.05). The amount of perivascu-
lar collagen correlated directly with medial thickness (r = 0.88, P < 0.01) and
volume of medial collagen (r = 0.57, p < 0.05). Thus, IMCAs in HCM are en-
cased in perivascular collagen and also show greatly thickened media due
in part to increased collagen. This substantial perivascular and medial colla-
gen potentially impairs vasoreactivity, in turn resulting in diminished coronary
blood flow and cell death. The findings provide a morphologic explanation for
myocardial ischemia, mediated by "small vessel disease", in pts with HCM.
During the transition from LVH to CHF, Ees was decreased and Vo was in-
creased. These changes in inotropic state and in ventricular shape were as-
sociated with a decrease in the MVOz intercept, while the slope of MV0z-
PYA relation was not altered. In conclusion, we confirm that the myocardial
contractility and the ventricular remodeling occur during the transition from
LVH to CHF in this animal model. Despite these changes, the oxygen cost
of contractility does not change and the total energy cost of the remodeling
myocardium might be preserved by reducing the expenditure for the non-
mechanical process which includes the E-C coupling.
Tumor necrosis factor-a (TN Fa) plays a role in the pathophysiology of my-
ocardial depression observed in septic shock and myocarditis. Limited re-
sponsiveness to inotropic therapy in these pathological states may be related
to cytokine mediated disruption of adrenergic signal transduction. In cul-
tured myocytes, TNFa reversibly inhibits isoproterenol mediated increases in
both contractility and intracellular cAMP accumulation via interference with
fi-adrenergic receptor coupling to adenylate cyclase. Whether TNFa alters
myocardial responsiveness to exogenous jl-adrenergic stimulation in the in-
tact animal has yet to be determined. Accordingly, we evaluated the effects of
dobutamine (Dob) in 9 conscious dogs, chronically instrumented with 3 sets
of diameter gauges and LV manometers, treated with a 1 hour infusion of
TNFa (40 /!g/kg). Mw, the slope of the relation between stroke-work and end-
diastolic volume, was determined before and after brief infusions of Dob (4
/!g/kg/min) at multiple times after TNFa. TNFa produced a reduction in base-
line contractile performance beginning 4 hours and extending to 25 hours
after initiation of infusion. The percentage increase of Mw induced by Dob
dropped from 34 ± 7% pre-TN Fa to a nadir of 15 ± 5% 3 hours post-TNFa, an
effect which persisted but then dissipated. Similar results were found when
end-systolic elastance and dP/dtmax were evaluated. We conclude thatTNFa
impairs myocardial responsiveness to fi-adrenergic stimulation in the intact
animal, an effect separate from its primary myocardial depressant properties.
